4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide

C36H51F2N9O2S — CID 178017661

IUPAC4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide
SMILESCNC(=O)CCC(C=O)c1nn(C)c2cc(N3CCC4(CC3)CN(CCCSN3CCC(Nc5ncc(CC(F)F)cn5)CC3)C4)c(C)cc12
InChIInChI=1S/C36H51F2N9O2S/c1-25-17-29-31(44(3)43-34(29)27(22-48)5-6-33(49)39-2)19-30(25)46-14-9-36(10-15-46)23-45(24-36)11-4-16-50-47-12-7-28(8-13-47)42-35-40-20-26(21-41-35)18-32(37)38/h17,19-22,27-28,32H,4-16,18,23-24H2,1-3H3,(H,39,49)(H,40,41,42)
InChIKeyNSLFPACMDHVTBN-UHFFFAOYSA-N
MW711.93 g/mol
LogP4.81
Rot. Bonds15

About 4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide

4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide (PubChem CID 178017661) has the molecular formula C36H51F2N9O2S and a molecular weight of 711.93 g/mol. Its IUPAC name is 4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide.

Molecular Properties

Compound Name4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide
PubChem CID178017661
Molecular FormulaC36H51F2N9O2S
Molecular Weight711.93 g/mol
Exact Mass711.39
IUPAC Name4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide
SMILESCNC(=O)CCC(C=O)c1nn(C)c2cc(N3CCC4(CC3)CN(CCCSN3CCC(Nc5ncc(CC(F)F)cn5)CC3)C4)c(C)cc12
InChIInChI=1S/C36H51F2N9O2S/c1-25-17-29-31(44(3)43-34(29)27(22-48)5-6-33(49)39-2)19-30(25)46-14-9-36(10-15-46)23-45(24-36)11-4-16-50-47-12-7-28(8-13-47)42-35-40-20-26(21-41-35)18-32(37)38/h17,19-22,27-28,32H,4-16,18,23-24H2,1-3H3,(H,39,49)(H,40,41,42)
InChIKeyNSLFPACMDHVTBN-UHFFFAOYSA-N
XLogP4.81
TPSA111.52 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds15
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500711.93
LogP ≤ 54.81
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'sulphur_nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide?
The IUPAC name of 4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide (CID 178017661) is 4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide.
What is the SMILES notation for 4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide?
The canonical SMILES for 4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide is CNC(=O)CCC(C=O)c1nn(C)c2cc(N3CCC4(CC3)CN(CCCSN3CCC(Nc5ncc(CC(F)F)cn5)CC3)C4)c(C)cc12.
What is the InChIKey of 4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide?
The InChIKey is NSLFPACMDHVTBN-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H51F2N9O2S/c1-25-17-29-31(44(3)43-34(29)27(22-48)5-6-33(49)39-2)19-30(25)46-14-9-36(10-15-46)23-45(24-36)11-4-16-50-47-12-7-28(8-13-47)42-35-40-20-26(21-41-35)18-32(37)38/h17,19-22,27-28,32H,4-16,18,23-24H2,1-3H3,(H,39,49)(H,40,41,42).
What are the key properties of 4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide?
4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide has a molecular weight of 711.93 g/mol, XLogP of 4.81, 15 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[6-[2-[3-[4-[[5-(2,2-difluoroethyl)pyrimidin-2-yl]amino]piperidin-1-yl]sulfanylpropyl]-2,7-diazaspiro[3.5]nonan-7-yl]-1,5-dimethylindazol-3-yl]-N-methyl-5-oxopentanamide is sourced from PubChem (CID 178017661), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).